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Exposure of organisms to repetitive mild hypoxia results in development of
brain hypoxic/ischemic tolerance and cross-tolerance to injurious factors of a
psycho-emotional nature. Such preconditioning by mild hypobaric hypoxia functions
as a “warning” signal which prepares an organism, and in particular the brain, to
subsequent more harmful conditions. The endogenous defense processes which are
mobilized by hypoxic preconditioning and result in development of brain tolerance
are based on evolutionarily acquired gene-determined mechanisms of adaptation and
neuroprotection. They involve an activation of intracellular cascades including kinases,
transcription factors and changes in expression of multiple regulatory proteins in
susceptible areas of the brain. On the other hand they lead to multilevel modifications
of the hypothalamic-pituitary-adrenal endocrine axis regulating various functions in the
organism. All these components are engaged sequentially in the initiation, induction
and expression of hypoxia-induced tolerance. A special role belongs to the epigenetic
regulation of gene expression, in particular of histone acetylation leading to changes in
chromatin structure which ensure access of pro-adaptive transcription factors activated
by preconditioning to the promoters of target genes. Mechanisms of another, relatively
novel, neuroprotective phenomenon termed hypoxic postconditioning (an application
of mild hypoxic episodes after severe insults) are still largely unknown but according
to recent data they involve apoptosis-related proteins, hypoxia-inducible factor and
neurotrophins. The fundamental data accumulated to date and discussed in this review
open new avenues for elaboration of the effective therapeutic applications of hypoxic
pre- and postconditioning.
Keywords: hypoxic preconditioning, hypoxic postconditioning, neuroprotection, hypoxic tolerance of the brain,
molecular mechanisms
Identification of the molecular and physiological mechanisms underlying the response of
organisms to environmental factors, in particular, to harmful injurious exposures represents one
of the major research problems in biology and medicine. To solve this problem is fundamentally
important for further elucidation of the endogenous mechanisms responsible for adaptation to
the environment, as well as for elaboration of the effective tools to increase the resistance of the
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organism and its most vulnerable organs, the heart and brain, to
detrimental external and internal factors.
The central place in the formation of various types of adaptive
reactions of the organism to environmental factors belongs to the
neural process of perception and transduction of the adaptogenic
signal which the famous Russian physiologist and Nobel prize
laureate Ivan Pavlov designated as a “warning” signal. One of
Pavlov’s disciples P. K. Anokhin further developed the concept of
“alarm” or “warning” activity as the basis for the phenomenon of
anticipatory reflection of reality which is a universal phenomenon
of life allowing to “anticipate the course of future events in
order to better adapt to the environment” (Anokhin, 1974).
According tomodern concepts, in the nervous system the process
of adaptation to possible damaging effects can manifest itself
by the following cascade: an adaptogenic stimulus (“warning”
signal, specifically injurious or stress factors of mild intensity)
induces reorganization of the plasticity of the elements of the
nervous system (neurons, synapses, glia). At the root of this
reorganization lies the processing of anticipatory reflection of
reality which prepares brain cells to the expected deleterious
exposures and is associated with an induction of evolutionarily-
acquired gene-determined protective mechanisms. As a result,
reprogramming of death/survival mechanisms in the brain
cells is activated leading to neuroprotection and compensation
of the deleterious effects. By means of such cascade events,
the “warning” signal results in environmentally-determined
adaptive change in the phenotype, and the process represents
an illustrative example of hormesis or neurohormesis. Hormesis
is a basic principle of physiology which is generally defined
as responses of cells or organisms to a factor which induces
stimulatory or beneficial effects at low doses and inhibitory or
adverse effects at high doses (Calabrese et al., 2010; Calabrese
and Mattson, 2011). A preconditioning phenomenon aimed at
adaptation to extreme factors is one of the typical examples of
the adaptogenic “warning” signaling and, therefore, of hormesis.
Thus, it is likely that various types of the preconditioning, as
well as other hormetic stimuli, share some common protective
mechanisms. From this point of view, elucidation of the
mechanisms launched by the hypoxic preconditioning can be
important in a broader context, shedding more light on the basic
phenomenon of hormesis.
THE PHENOMENON OF
PRECONDITIONING
The terms “preconditioning” and “tolerance” were introduced
into experimental practice in 1964 (Janoff, 1964). At the end
of the last century Murry and colleagues demonstrated that
multiple brief ischemic episodes might actually protect the
myocardium from a subsequent sustained ischemic insult, and
this phenomenon has been termed “ischemic preconditioning”
(Murry et al., 1986). In the 1990s a hypoxic/ischemic tolerance
induced by pre-exposure to brief (sublethal) preconditioning
ischemic episodes has been described and partially studied in the
brain (Kitagawa et al., 1990; Kirino et al., 1991). In the next 25
years the mechanisms of cerebral ischemic preconditioning have
been uncovered in various in vivo and in vitro models including
global and focal brain ischemia, surviving brain slices, cultured
primary neurons and transient ischemic attacks in humans (for
review see Kirino, 2002; Steiger and Hänggi, 2007; Obrenovitch,
2008; Shpargel et al., 2008; Gidday et al., 2013). According to the
current concept, formation of brain ischemic tolerance induced
by ischemic preconditioning consists of two sequential phases
(“windows”): the early (an induction of tolerance) and the late
(an expression of tolerance) phase (Kirino, 2002; Steiger and
Hänggi, 2007; Stenzel-Poore et al., 2007; Shpargel et al., 2008).
The first window involves rapidly-induced (from a few minutes
to several hours) changes in the cells such as activation of protein
kinases, proteases, posttranslational modifications of ion channel
proteins, receptors, redox-sensitive proteins and, apparently,
immediate early gene transient expression. In the second window
(24 h and later) the delayed mechanisms associated with gene
expression and de novo synthesis of proteins providing long-
lasting plasticity and neuronal survival are being activated.
HYPOXIC PRECONDITIONING
Compared to ischemic preconditioning, effects and mechanisms
of preconditioning by mild or moderate hypoxic or anoxic
episodes (hypoxic preconditioning) have been understudied
although this paradigm obviously represents a convenient
method of treatment since it does not require surgery. The
phenomenon was first described in the 1960s as “a kind
of induced tolerance of tissue-cells to hypoxia” (Lu, 1963).
The neuroprotective action of brief anoxic pre-exposure was
reported in 1964 (Dahl and Balfour, 1964) almost 30 years
earlier than cerebral ischemic precondition had been described.
Further progress in developing the concept of hypoxic (anoxic)
preconditioning and brain tolerance has been achieved in the
in vitro electrophysiological studies on rat hippocampal slices
performed by Schurr and colleagues (Schurr et al., 1986).
One of the earliest models for studying hypoxic
preconditioning was autohypoxia. This represents a whole-
body preconditioning when anesthetized rodents are placed into
an individual sealed container, and authohypoxia is induced by
the animal’s own oxygen consumption (Lu, 1963). When such a
procedure is repeated up to 5 times, the animal becomes more
tolerant because the survival time (as judged by the onset of
gasping) was found to increase up to 8 times as compared to
control non-preconditioned animals (Lu et al., 1999).
Following this paradigm, the most common technique
for studying hypoxic preconditioning was the use of 8–13%
normobaric hypoxia. To achieve this, animals are usually placed
in a hypoxic chamber in which oxygen content is decreased
by substituting it with nitrogen. Humans can inhale such a
hypoxic gas mixture through a mask (Serebrovskaya et al., 2011),
which represents a non-invasive way of application and a more
beneficial technique compared to the ischemic methods with
regard to their implementation in clinical practice. Although the
therapeutic window of the normobaric hypoxia preconditioning
appears to be rather narrow lasting only approximately 72 h
(Stetler et al., 2014), it has been reported that various regimes
of normobaric hypoxic preconditioning significantly protect
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animals against injurious effects of subsequent global or focal
stroke (Miller et al., 2001), kainic acid-induced seizures and
brain edema (Emerson et al., 1999a,b). Numerous developmental
studies applying normobaric hypoxic preconditioning at the
early stages of ontogenesis demonstrated neuroprotection from
ischemic brain injury in different peri- and postnatal periods
(Gidday et al., 1994; Vannucci et al., 1998).
In vitro models of cerebral hypoxic preconditioning include
studies in hippocampal slices (Pérez-Pinzón et al., 1996; Bickler
and Fahlman, 2009) and olfactory cortex (Semenov et al.,
2002; Samoilov et al., 2003), as well as primary neuronal
cultures (Arthur et al., 2004). It has been demonstrated that
preconditioning with a single short (2min) episode of anoxia in
slices of the olfactory cortex or three trials of 1min anoxia in the
hippocampal slicesincreases the resistance of the cells to severe
“test” anoxia, preventing depression of the evoked potential
amplitudes and calcium overload associated with anoxic injury
whereas moderate calcium load is required for induction of
tolerance during anoxic preconditioning (Pérez-Pinzón et al.,
1999; Semenov et al., 2012).
HYPOBARIC HYPOXIC
PRECONDITIONING
Another promising technique of hypoxic preconditioning with
high translational potential is exposure to mild hypobaric
hypoxia. The revitalizing effects of moderate high altitude
occurring in nature have been known for centuries. Currently it is
well-established that adaptation (acclimatization) to high altitude
both of natural origin and simulated in the hypobaric chamber
has a number of beneficial effects on human health, whole
body hypoxic tolerance and improvement of physical training
(Meerson, 1984; Meerson et al., 1996; Millet et al., 2013). These
effects are observed under conditions of chronic mild hypobaric
hypoxia (acclimatization mode) and result from reprogramming
of the cardio-pulmonary and metabolic processes, including
erythropoiesis, vascular remodeling, pulmonary changes and
cardiac hypertrophy (Hultgren and Miller, 1967; Savourey et al.,
2004; Brito et al., 2015). The integrity of these reactions is
called systemic “structural trace of adaptation” due to which
the resistance of an organism against any forthcoming hypoxic
exposures is achieved along with more general protective effects
(Meerson, 1984).
Hypobaric hypoxia is also widely used in the mode of
intermittent (multiple, interlaced by normoxic periods) hypoxic
training adapted as a therapeutic strategy to treat heart diseases,
allergy (Meerson et al., 1987) and for training of athletes
to improve their sea-level performance (Levine, 2002). In
experimental practice the neuroprotective and anticonvulsant
potential of chronic intermittent hypobaric hypoxia has also been
demonstrated (Gong et al., 2012; Zhen et al., 2014).
In our laboratory during several years we have been using
an original technique of hypobaric hypoxic preconditioning
which was developed in early 2000s and consistently validated
in subsequent studies (Samoilov et al., 2001; Rybnikova et al.,
2005, 2006). With this method, three trials of mild hypobaric
hypoxia (360mm Hg, equivalent to 10% of normobaric oxygen
and an altitude of 5 km above sea level, 2 h duration of each
episode) spaced at 24 h are necessary and sufficient to achieve
the most pronounced neuroprotective effect and significantly
protect the brain against subsequent severe global hypoxia. Such
a mode of hypoxic preconditioning has greatly improved survival
of rats during severe hypoxia (3 h, 180mm Hg, equivalent to 5%
of normobaric oxygen and an altitude of 11 km) and prevented
hypoxia-induced injury/loss of vulnerable brain neurons in the
hippocampus and neocortex, as well as diminished functional
disturbances observed at the behavioral level (Samoilov et al.,
2001; Rybnikova et al., 2005). Surprisingly, preconditioning by
three episodes of mild hypobaric hypoxia has also demonstrated
a potent antidepressant-like and anxiolytic action and protected
animals from development of stress-related depressions and
anxiety (Rybnikova et al., 2007a). The neuroprotective efficacy of
such a preconditioning mode against an ischemic brain injury
was further proved by another research group in a model of
global cerebral ischemia in gerbils (Duszczyk et al., 2009) and also
in a model of cardiac arrest and resuscitation (Xu and Lamanna,
2014).
CEREBRAL MECHANISMS OF HYPOXIC
PRECONDITIONING
A central place in the studies of hypoxic preconditioning
belongs to identification of its molecular mechanisms with
special attention being paid both to their unique character and
similarity with the mechanisms of ischemic preconditioning.
The process of preconditioning can be divided into several
phases starting with the phase of initiation of hypoxic tolerance
(Samoilov, 1997; Samoilov et al., 2003) or the immediate phase of
adaptation to hypoxia (Lukyanova et al., 2013) which covers the
first few minutes following the exposure to moderate hypoxia.
This acute stage is clearly linked with the launch of several
molecular signaling processes. The important mechanism which
significantly contributes to the development of the later phases
of brain hypoxic tolerance is obviously associated with the
acute changes in neuronal redox state in favor of reduction
equivalents that, in turn, can result in modifications of calcium
bound to intracellular hydrophobic components (for review
see Samoilov et al., 2003). Another key process at this stage
is a remodeling of the respiratory mitochondrial chain and
switching to the mitochondrial complex II, as well as rapid
and transient activation of hypoxia-inducible factor HIF-1
(Lukyanova et al., 2009, 2012). Succinate-induced stabilization
of HIF-1α followed by an activation of the transcriptional factor
HIF-1 and expression of its target pro-adaptive genes is currently
considered as one of the main mechanisms contributing to
development of the long-term adaptation to hypoxia (Lukyanova
et al., 2009).
The second phase of hypoxic preconditioning, the phase of
induction of long-term hypoxic tolerance, involves significant
alterations of the intracellular signal transduction processes,
primarily modest activation of the glutamatergic, calcium,
phosphoinositide, cyclic AMP regulatory systems (Semenov
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et al., 2000, 2002; Samoilov et al., 2003) and rapid changes in
pro- and antioxidant reactions (Ravati et al., 2000: Furuichi et al.,
2005). This is followed by fast protein kinase- and protease-
dependent modifications of ion channels, receptors, redox-
sensitive proteins, as well as triggering of the third phase—the
phase of expression of hypoxic tolerance. The question arises
what signal mechanisms are responsible for the transformation
of the hypoxic tolerance induction phase into the phase of its
long-term expression.
As in cerebral ischemic tolerance, formation of the delayed
phase of brain tolerance (thephase of expression) induced
by hypoxic preconditioning is associated with activation of
pro-adaptive genes and expression of their products which
affect intracellular plasticity readjustment aimed at retention of
vital neuronal functions and structural integrity. A principal
role in controlling genome activity belongs to so-called third
messengers—transcription factors which are activated in the
cytosol, translocated to the nucleus and which bind to the
promoters of target genes regulating their transcription (Morgan
and Curran, 1991). The transcription factors are activated by
intracellular components of calcium, phosphoinositide, cyclic
AMP and pro-oxidant regulatory systems and therefore link two
sequential phases of hypoxic/ischemic tolerance development,
namely the phases of its induction and expression.
The main activators of the late-response genes engaged in
the mechanisms of neuronal plasticity and survival include
inducible (c-Fos, NGFI-A, HIF-1) and ubiquitous (pCREB,
NF-κB) transcription factors. Inducible transcription factors
are products of immediate early genes whose expression is
driven by signaling cascade-dependent remodeling of chromatin
enzymes and modifications of histones, as well as by interaction
with ubiquitous transcription factors (Morgan and Curran,
1991; Sng et al., 2004). The hypoxia-inducible factor HIF-1α
is stabilized and activated under hypoxic conditions due to
hypoxia-dependent inactivation of prolyl hydroxylase reactions
and is also controlled by NF-κB, NGFI-A, MAP/ERK (Kallio
et al., 1999; Samoilov et al., 2007). Ubiquitous transcription
factors CREB, NF-κB are activated by phosphorylation and
factors of cellular stress (cytokines, reactive oxygen species, Ca2+i )
(Mattson et al., 2000; Ravati et al., 2000; Kitagawa, 2007).
Until recently, only scattered non-systematic data on the
nature of the involvement of various transcription factors
in the mechanisms of expression of brain hypoxic tolerance
have been reported. Using our model of hypobaric hypoxic
preconditioning, a complex study of the expression and activity
profiles of the key transcription factors in the rat brain has
been performed over the years which allowed us to conclude
that neuroprotective hypoxic preconditioning by three episodes
of mild hypobaric hypoxia induces persistent (up to 24 h)
neuronal overexpression of inducible (c-Fos, NGFI-A, HIF-1α)
and activation of ubiquitous (pCREB, NF-kB) transcriptional
factors in the most vulnerable brain regions including the
fronto-parietal neocortex and various hippocampal fields (CA1,
CA3/4, dentate gyrus) (Rybnikova et al., 2008a, 2009). Although
we have observed some specific changes characteristic to the
neocortex and different areas of the hippocampus (Figure 1) it
is noteworthy that despite the different levels of expression of
FIGURE 1 | Schematic representation of activating effect of hypobaric
hypoxic preconditioning on the transcription factors NGFI-A, c-Fos,
HIF-1 in various areas of hippocampus and neocortex (Rybnikova
et al., 2009, 2015).
the transcription factors their cooperative “cross” activation was
observed in all examined brain structures in preconditioned rats.
More recent results indicate that the cooperative induction
of transcription factors can be attributed to the hypoxia-
tolerant phenotype depending on the efficacy and mode of
hypoxic preconditioning. Strong activation of neuronal CREB
(its phosphorylation) and NF-κB p65 in the neocortex has
been observed following the three-trial but not the single-
trial preconditioning (Samoilov et al., 2014). In contrast to the
three-trial preconditioning, the single preconditioning trial does
not result in formation of the hypoxia-tolerant phenotype and
provides no protection against the structural and functional
injury produced by severe hypoxia.
It is well-known that downstream targets for the transcription
factors NGFI-A, c-Fos, HIF-1α, pCREB, and NF-κB include
genes encoding pro-adaptive proteins: neurotrophins,
antioxidants, anti-apoptotic factors of the bcl-2 superfamily,
heat shock proteins, erythropoietin and others, involved in
the processes of neuroplasticity and neuronal survival during
harmful exposures (Sheng and Greenberg, 1990; Finkbeiner,
2000; Mattson et al., 2000; Semenza, 2000; Rice et al., 2002;
Merelli et al., 2013, etc.). Based on this knowledge it can
be hypothesized that the cooperative activation of these
transcription factors in the brain (“warning” signaling at the
level of the genome) promote the most intense expression of the
pro-adaptive genes which are essential for preventing the injury
of the susceptible brain neurons caused by damaging factors.
One of the most important common mechanisms of
ischemic and hypoxic preconditioning involves reprogramming
of apoptosis-related processes. Both types of preconditioning
up-regulate expression of anti-apoptotic proteins of the Bcl-
2 superfamily and repress the levels of Bax (Rybnikova et al.,
2006; Liu et al., 2009). A complex of survival-enhancing,
neuroprotective and neuroplasticity processes is induced by
hypoxic preconditioning in the phase of expression at the level
of late-response genes and de novo synthesis of the protein
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products. The most substantial contributions to the hypoxia-
tolerant phenotype have been ascribed to the up-regulation of
mitochondrial and cytosolic antioxidant enzymes (Lin et al.,
2003; Arthur et al., 2004; Stroev et al., 2004, 2005; Shao
and Lu, 2012), neurotrophin BDNF (Samoilov et al., 2014),
erythropoietin (Bernaudin et al., 2000, 2002a; Grimm et al.,
2006), adrenomedullin (Tixier et al., 2008), the dampening
of the excitotoxicity by down-regulation of AMPA receptors
(Chang et al., 2006) and stimulation of group I metabotropic
glutamate receptors (Semenov et al., 2012). A target of HIF-1
vascular endothelial growth factor VEGF was also shown to be
intensely up-regulated (Bernaudin et al., 2002b) which appears
to promote extensive neurovascular remodeling as described for
hypoxic preconditioning recently (Boroujerdi and Milner, 2015).
Among other protective mechanisms, an induction of heat shock
proteins, in particular Hsp70 has also been demonstrated in a
model of hypobaric hypoxic preconditioning (Wang et al., 2012).
Adenosine content and adenosine A1 receptor affinity in the
hippocampus of rats preconditioned by repetitive autohypoxia
are markedly higher than those in non-preconditioned animals
or animals preconditioned by a single trial (Zhang and Lu,
1997). Comparing the changes in the neuropeptide Y levels
in gerbil hippocampus in two models of preconditioning,
hypobaric hypoxic and ischemic, Duszczyk and colleagues have
demonstrated that ischemic preconditioning caused a 20% rise in
the expression of neuropeptide Y which lasted for 4 days, whereas
hypobaric hypoxic preconditioning according to our protocol
resulted in a two-fold increase in the neuropeptide Y levels that
was maintained for at least 7 days (Duszczyk et al., 2009).
Our recent study has also reported that hypoxic
preconditioning differentially alters the expression of specific
proteins called ADAMs (a disintegrin and metalloprotease).
ADAMsare a family of membrane-anchored glycoproteins
capable of shedding a multitude of proteins from the cell surface
(van Goor et al., 2009). Various ADAMs act as crucial modulators
of physiological and pathophysiological processes and are
supposed to contribute to control of neuronal death/survival.
Hypoxic preconditioning induces prominent overexpression
of ADAM17 mRNA and protein in the hippocampus and
neocortex and prevented severe hypoxia-induced up-regulation
of ADAM 15 linked to the neuronal injury (Rybnikova et al.,
2012a). These findings might be of special importance in the
focus of neurodegeneration since some of the ADAMs including
ADAM10 and ADAM17 (TACE) function as amyloid precursor
protein (APP) α-secretases (Allinson et al., 2003). For this
reason, the observed up-regulation of ADAM17 corresponded
to a higher level of the soluble form of APP produced in
response to hypobaric hypoxic preconditioning may predict
some therapeutic properties for this technique in prevention of
Alzheimer’s disease. The restoration of the ischemia-reduced
α-secretase activity and expression of the amyloid-degrading
enzymes neprilysin and endothelin-converting enzyme has been
reported in other models of hypoxic preconditioning (Nalivaeva
et al., 2004).
A specific group of ligand-operated transcription factors is
represented by receptors of corticosteroid hormones. There are
two subtypes of such receptors differing in their characteristics,
affinity, localization and functions, namely glucocorticoid and
mineralocorticoid receptors. Both receptor subtypes are found
in the brain and play important roles in adaptive behavior
and endocrine regulation, in particular, in feedback control
of the hypothalamic-pituitary-adrenal axis (HPA) exerted by
glucocorticoid hormones. To date the functions of gluco- and
mineralocorticoid receptors, and especially of their balance, have
been expanded to participation in the processes of neuronal
death/survival and neuroplasticity (de Kloet et al., 1998; De Kloet
et al., 2005; Almeida et al., 2000; Rogalska, 2010). Our studies
have demonstrated that three trials of hypoxic preconditioning
considerably affected expression of gluco- and mineralocorticoid
receptors in the dorsal and ventral hippocampus, achieving their
optimal balance for neuronal survival (Rybnikova et al., 2011)
while the single-trial preconditioning exhibited such an effect to
a much lesser extent.
The preconditioning-induced changes in brain corticosteroid
receptors appear to contribute to the improvement of adaptive
capabilities of the whole organism. This is supported by
the analysis of survival rates in preconditioned vs. non-
preconditioned rats under the conditions of acute lethal hypoxia.
As mentioned above, hypoxic preconditioning in our model
of hypobaric hypoxia significantly decreased the lethality of
rats during 3 h of exposure to severe hypoxia (down to 15%).
This allowed us to suggest that such preconditioning results in
mobilization of systemic mechanisms of adaptation, primarily
of those associated to the functioning of HPA responsible for
organization of the adaptive stress response (Selye, 1950). Further
evidence substantiating this suggestion has been obtained in
our experiments showing that effective hypoxic preconditioning
enhances the activity and reactivity of HPA to mild stresses
and potentiates the negative glucocorticoid feedback (Rybnikova
et al., 2007b, 2008b, 2011). No such effect has been seen for
the non-effective preconditioning mode. Very recently Feng and
Bhatt (2015) have also described similar changes in HPA activity
in the model of normobaric hypoxic preconditioning and shown
that the glucocorticoid receptor blocker RU486 significantly
inhibited hypoxic PC induced neuroprotection in newborn rats
(Feng and Bhatt, 2015). Hence it is obvious that one of the most
important and universal protective mechanisms launched by the
hypoxic preconditioning is the modification of HPA functioning
aimed at the optimal mobilization of the pro-adaptive defenses.
It is interesting to note that modifications of HPA appear to
represent a specific target for the adaptogenic effects of high
altitudes, since they are observed also during high altitude
acclimatization and training (Meerson et al., 1996).
In addition to normobaric and hypobaric hypoxic
preconditioning, molecular mechanisms of neuroprotection
have been extensively studied in the autohypoxic model. In
contrast to other models of hypoxic or ischemic preconditioning,
a number of pro-adaptive factors were down-regulated in
the brains of rats preconditioned by episodes of autohypoxia,
including pERK1/2, calcium, excitatory amino acids, nitric
oxide, expression of alpha synuclein (Shao and Lu, 2012). On the
other hand, enzyme antioxidants, CREB-dependent signaling,
and expression of HIF-1 and its target molecule VEGF are
up-regulated in the vulnerable brain regions as has been reported
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for other models. These findings suggest that autohypoxic
preconditioning is a model which shares with other models some
common mechanisms but differs in its specific features.
An important role of systemic mechanisms for whole-body
models of hypoxic preconditioning (autohypoxia, hypobaric
hypoxia) might be expected due to an apparent contribution
of remote conditioning. The remote preconditioning is a
phenomenon in which brief hypoxic/ischemia and reperfusion
of one organ increases tolerance in a remote organ (for
review see Przyklenk and Whittaker, 2013). In addition,
the remote ischemic preconditioning increased resistance of
the whole organism to hypobaric hypoxia at high altitude,
preventing development of high altitude diseases (Berger et al.,
2015). Until recently this phenomenon has been attributed
only to the ischemic models (Vijayakumar et al., 2015),
however accumulating evidence suggests that in addition to
transient ischemia other triggers of remote protection should be
introduced, including peripheral nociception, direct peripheral
nerve stimulation and electroacupuncture (Heusch et al., 2015).
Taking in consideration that during hypoxic preconditioning
episodes in the whole-body models all organs and tissues of
the body are exposed to the preconditioning hypoxia, systemic
mechanisms of remote preconditioning are likely to contribute
to the increased tolerance of the brain. A review of the literature
gives evidence for both humoral and neural mechanisms of
remote preconditioning (Meller and Simon, 2015). Plausible
candidates of humoral mediators include plasma microRNA-
144 and ATP-sensitive potassium channels of red blood cells
(Gopalakrishnan and Saurabh, 2014; Li et al., 2014) but their
importance for protecting the brain has not been demonstrated.
In contrast to cardioprotection, for neuroprotection resulting
from the remote preconditioning there is more evidence on
the neural mechanisms, because blocking neural inputs to
the central nervous system prevented remote-preconditioning-
induced brain protection (Malhotra et al., 2011; Meller and
Simon, 2015). Surprisingly, remote ischemic preconditioning, in
contrast to our model of hypobaric hypoxia and normobaric
hypoxic preconditioning in the newborn, failed to induce a
detectable increase in circulating cortisol as recently reported by
Birkelund and colleagues (Birkelund et al., 2015).
New and perspective avenues in research into hypoxic
preconditioning and brain tolerance involve epigenetic
regulation. Recently, it has been reported that methylation
of DNA may be involved in the neuroprotection achieved
by hypoxic preconditioning (Zhang et al., 2014). The role of
other epigenetic mechanisms in the hypoxic preconditioning
has not been studied although an involvement of changes at
the epigenetic level in cellular responses to hypoxia/ischemia,
in particular in the brain, became a subject of several studies
(Watson et al., 2010; Perez-Perri et al., 2011; Melvin and Rocha,
2012; Schweizer et al., 2013; Wu et al., 2013; Tsai and Wu, 2014).
As noted above, a key role in the formation of preconditioning-
induced brain tolerance belongs to the cooperative activation
of several transcription factors, HIF-1α being one of the most
important. It is known that HIF-1 requires co-activators which
modify chromatin structure, opening the access to DNA for
the regulators of transcription. HIF-dependent co-activators
include histone acetyltransferases, CREB-binding protein (CBP)
and p300 (Ema et al., 1999), some histone deacetylases (Kato
et al., 2004; Ellis et al., 2009; Seo et al., 2009) and a chromatin
remodeling complex SWI/SNF (Wang et al., 2004). Binding
of CBP to the CRE elements of gene promoters dependent on
pCREB activity is also up-regulated by hypoxic preconditioning,
as described above. Thus, involvement of epigenetic mechanisms
can be currently expected both at the level of protein-protein
interactions with transcriptional regulators and the acetylation
of histones followed by chromatin relaxation. However, this
hypothesis requires further experimental substantiation, which
we are currently working on.
HYPOXIC POSTCONDITIONING
Intensive research into ischemic preconditioning in the
1990s–2000s inspired establishment of a cognate protective
phenomenon—ischemic postconditioning. It has been
demonstrated that repetitive brief ischemia applied after
prolonged coronary occlusion, during early reperfusion (such
a mode has been termed postconditioning) is cardioprotective
by attenuating reperfusion after myocardial injury (Zhao
et al., 2003). A link to the brain was suggested later, in
2007 (Zhao, 2007), and the first experimental studies of this
research group described the neuroprotective effects of ischemic
postconditioning in stroke with a putative role suggested for Akt
signaling (Gao et al., 2008) that is similar to the mechanisms of
ischemic preconditioning. Further studies on cerebral ischemic
postconditioning to date provide controversial results and many
issues remain to be solved regarding its possible protective effects
and feasibility (Leger et al., 2015).
A neuroprotective potential of hypoxic postconditioning has
been thoroughly described for the first time using chronic
intermittent normobaric hypoxia in mice (Leconte et al., 2009).
It has been demonstrated that later application of hypoxia
(1 h, 8% O2, 1–5 days) after the focal ischemia significantly
reduced delayed thalamic atrophy. The same study reported
that hypoxia in vitro (0.1, 1, or 2% O2) performed 14 h after
oxygen glucose deprivation induced neuroprotection in primary
neuronal cultures and pointed out the causal mechanistic role for
HIF-1α and its target genes erythropoietin and adrenomedullin
in this process.
Recently, based on our original studies of hypobaric
hypoxic preconditioning, we developed a model of hypobaric
hypoxic postconditioning in rats which involves mild hypoxic
exposures (360mm Hg, 2 h) spaced at 24 h applied either 3
or 24 h after severe hypoxia. It was found that both early
and delayed applications of the postconditioning episodes
remarkably improved recovery from severe hypoxia and
attenuated posthypoxic neuronal injury, reducing pyknosis,
hyperchromatosis, and interstitial brain edema, as well as the
rates of neuronal loss in the hippocampus and neocortex.
Besides that, the delayed postconditioning exerted a potent
anxiolytic effect on rat behavior, preventing development of
posthypoxic anxiety. Both modes of postconditioning had a
beneficial effect on the functioning of HPA, but only the
delayed postconditioning completely returned HPA to its
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FIGURE 2 | Cascade of molecular mechanisms involved in brain hypoxic tolerance induced by hypoxic preconditioning. See references in the text
relevant to this Figure.
baseline activity and reactivity to stress (Rybnikova et al.,
2012b). Furthermore, such a mode of postconditioning enhanced
expression of HIF-1α and erythropoietin in the hippocampal
CA1 neurons of rats surviving after severe hypoxia (Vetrovoy
et al., 2014). The modifications of apoptosis-related processes
and up-regulation of the neurotrophins (BDNF) has also
been implicated in the compensatory mechanisms induced by
hypobaric hypoxic postconditioning (Vetrovoy et al., 2015).
In parallel to our studies, it has recently been reported that
hypobaric hypoxic postconditioning reduces brain damage and
improves antioxidative defense in the rat model of birth asphyxia
(Gamdzyk et al., 2014).
CONCLUSIONS
To summarize the facts and hypothesis discussed above,
it should be stated that hypoxic preconditioning functions
as a “warning” signalization which mobilizes evolutionarily
acquired genome-determined urgent defense mechanisms of
brain neurons and the organism as a whole. The processes
resulting in their increased resistance to injurious challenge
involve induction of multiple intracellular signal components,
as well as adjustment of the neuroendocrine control of
HPA function. Hypoxic preconditioning-induced cascade
mechanisms of intracellular signaling include changes at the
level of intracellular redox status, mitochondrial respiratory
chain, key second messenger systems, receptor machinery,
transcription factors, early and late-response genes which are
sequentially engaged in the initiation, induction and expression
of the brain hypoxic tolerance (Figure 2). A cooperative
activation of the ubiquitous, ligand-operated and inducible
transcriptional factors plays the key role for development of
the rigorous phase of tolerance expression. Studying the impact
of epigenetic regulation in mediating the neuroprotective
effects of hypoxic pre- and postconditioning represents a novel
perspective trend in this research. Although it is apparent that
the main neuroprotective mechanisms of hypoxic pre- and
postconditioning might be overlapping this hypothesis needs
further investigation.
Based on the notable recent progress in our current knowledge
of hypoxic pre- and postconditioning, it is obvious that
these techniques possess high translational potential and can
inspire development of novel feasible neuroprotective tools for
prophylaxis and treatment of neurological, neurodegenerative
and stress-related disorders, as well as for increasing of
the adaptive capacities of the organism and the brain. It
is necessary to consider that adjustment of the particular
mode of hypoxic pre- and postconditioing elaborated on
the basis of fundamental mechanistic data is principally
important for the effective application of their protective
potential.
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